Johnson & Johnson Vision Appoints New Regional Presidents

Johnson & Johnson Vision has announced the appointment of Lori Tierney as President, Americas; Jacqueline Henderson as President, EMEA; and Christoph Vonwiller as President, Asia Pacific.

Ms. Tierney brings her experience as the former President of Americas for the Vision Care business, while Ms. Henderson previously held the position of Area Vice President, EMEA for Vision Care, and Mr. Vonwiller served as Regional Vice President, APAC for Surgical Vision.

“We’re delighted to have Lori, Jacqueline and Christoph leading our regional businesses at such an exciting time for our company,” said Peter Menziuso, Johnson & Johnson Vision’s Company Group Chairman. “As we evolve our organization in ways that allow us to operate as a more unified, integrated, and aligned Johnson & Johnson Vision team, their combined dynamic leadership, strong customer-centricity, and passion for delivering better patient outcomes will lead our Americas, EMEA and Asia Pacific businesses to future growth.”

In addition, Jun Morimura will continue to serve as President for Vision Care, Japan.

Before joining Johnson & Johnson Vision, Lori Tierney held the position of Worldwide President for Mentor, overseeing the end-to-end business for the breast aesthetic brand. She also served as Vice President, Commercial Operations for J&J Medical Devices North America, and had leadership roles at AstraZeneca, Endo International, and Centocor.

Jacqueline Henderson has been with Johnson & Johnson for over two decades, starting in the Consumer Products division in 1996 and holding various sales and marketing leadership roles in global and local operating companies. She later moved to the Medical Device sector as General Manager of Johnson & Johnson Vision Care Canada, and eventually became Vice President of Marketing North America.

Mr. Vonwiller joined Johnson & Johnson in 2005 and assumed the role of General Manager for Cordis & Lifescan within Johnson & Johnson Medical Australia & New Zealand shortly thereafter. He subsequently transitioned to the position of General Medicine Business Unit Director for Janssen Australia, and later served as the Vice President and Metabolism Commercial Leader.